134 related articles for article (PubMed ID: 28353375)
1. Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings.
Das S; Fleming DH; Mathew BS; Winston A B; Prabhakar AT; Alexander M
Hosp Pract (1995); 2017 Apr; 45(2):46-50. PubMed ID: 28353375
[TBL] [Abstract][Full Text] [Related]
2. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
Kong ST; Lim SH; Chan E; Ho PC
J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry.
Shokry E; Villanelli F; Malvagia S; Rosati A; Forni G; Funghini S; Ombrone D; Della Bona M; Guerrini R; la Marca G
J Pharm Biomed Anal; 2015 May; 109():164-70. PubMed ID: 25770414
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.
Kong ST; Lim SH; Lee WB; Kumar PK; Wang HY; Ng YL; Wong PS; Ho PC
PLoS One; 2014; 9(9):e108190. PubMed ID: 25255292
[TBL] [Abstract][Full Text] [Related]
5. Comparison between the Cobas Integra immunoassay and high-performance liquid chromatography for therapeutic monitoring of carbamazepine.
Hermida J; Bóveda MD; Vadillo FJ; Tutor JC
Clin Biochem; 2002 May; 35(3):251-4. PubMed ID: 12074835
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
Vasudev A; Tripathi KD; Puri V
Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
[TBL] [Abstract][Full Text] [Related]
7. Dried Blood Spot Self-Sampling by Guardians of Children With Epilepsy Is Feasible: Comparison With Plasma for Multiple Antiepileptic Drugs.
Linder C; Neideman M; Wide K; von Euler M; Gustafsson LL; Pohanka A
Ther Drug Monit; 2019 Aug; 41(4):509-518. PubMed ID: 30807537
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: no interference with carbamazepine and its metabolites.
Alves G; Fortuna A; Sousa J; Direito R; Almeida A; Rocha M; Falcão A; Soares-da-Silva P
Ther Drug Monit; 2010 Aug; 32(4):512-6. PubMed ID: 20592643
[TBL] [Abstract][Full Text] [Related]
9. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
10. Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs.
Min KL; Ryu JY; Chang MJ
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):215-236. PubMed ID: 31199557
[TBL] [Abstract][Full Text] [Related]
11. Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of carbamazepine and its main metabolites.
Härtter S; Jensen B; Hiemke C; Leal M; Weigmann H; Unger K
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):253-8. PubMed ID: 9698248
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
Krasniqi S; Neziri B; Islami H; Bauer S
Med Arh; 2010; 64(2):80-3. PubMed ID: 20514770
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
[TBL] [Abstract][Full Text] [Related]
15. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
[TBL] [Abstract][Full Text] [Related]
16. Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma.
Ma J; Zhu PL; Xie JW; Jia ZP; Yang JS
Acta Pharmacol Sin; 2002 Jan; 23(1):87-91. PubMed ID: 11860744
[TBL] [Abstract][Full Text] [Related]
17. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots.
Shah NM; Hawwa AF; Millership JS; Collier PS; McElnay JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():65-73. PubMed ID: 23474834
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography.
Yoshida T; Imai K; Motohashi S; Hamano S; Sato M
J Pharm Biomed Anal; 2006 Jun; 41(4):1386-90. PubMed ID: 16597494
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Irshaid YM; Hamdi AA; Al Homrany M
Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
[TBL] [Abstract][Full Text] [Related]
20. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary?
Burianová I; Bořecká K
Clin Biochem; 2015 Sep; 48(13-14):866-9. PubMed ID: 26018946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
